In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban
Journal of Thrombosis and Haemostasis2013Vol. 11(6), pp. 1111–1118
Citations Over TimeTop 10% of 2013 papers
Related Papers
- → Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated Thrombography(2020)18 cited
- → Favorable Outcome of Rivaroxaban-Associated Intracerebral Hemorrhage Reversed by 4-Factor Prothrombin Complex Concentrate(2015)10 cited
- → Concomitant assessment of rivaroxaban concentration and its impact on thrombin generation(2019)6 cited
- → Comment on the use of computational models to study the effect of apixaban and rivaroxaban on thrombin generation(2015)3 cited
- → Efficacy of prothrombin complex concentrate for reversal of major bleeding due to rivaroxaban: A pilot randomized controlled trial(2020)1 cited